5-methylcytosine has been researched along with Prostatic Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belengeanu, V; Grelus, A; Ioiart, I; Miklos, I; Nica, DV; Popescu, C | 1 |
| Bedford, MT; van Helden, PD | 1 |
2 other study(ies) available for 5-methylcytosine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Clinical Significance of Measuring Global Hydroxymethylation of White Blood Cell DNA in Prostate Cancer: Comparison to PSA in a Pilot Exploratory Study.
Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Humans; Leukocytes; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms | 2017 |
Hypomethylation of DNA in pathological conditions of the human prostate.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA; Humans; Male; Mathematics; Methylation; Prostatic Hyperplasia; Prostatic Neoplasms | 1987 |